GlassScriptPhysician profile
Marianne Sanchez
NPI 1982790531
$7,195.48
in general payments reported to CMS, 2019-2025
43 companies · $837 in 2025
The $837 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $1,038 · 2021: $1,298 · 2022: $1,392 · 2023: $917 · 2024: $875 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,554 · Education: $61.00 · Entertainment: $13.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.90 |
| Education | $61.00 |
| Entertainment | $13.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,335.07 | 2019-2025 | Repatha, Otezla, Prolia |
| Astellas Pharma US INC | $816.09 | 2019-2024 | Veozah, Myrbetriq |
| Novo Nordisk INC | $714.88 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $669.99 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $553.02 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $402.34 | 2019-2025 | Breztri, Farxiga |
| Pfizer INC. | $245.06 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $228.19 | 2019-2024 | Belsomra, Gardasil, Capvaxive |
| Exact Sciences Corporation | $214.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $213.81 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $175.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.89 | 2019-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $158.44 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $144.72 | 2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $140.10 | 2019-2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $104.24 | 2019-2021 | |
| Esperion Therapeutics, INC. | $94.03 | 2022-2025 | Nexletol |
| Tris Pharma INC | $76.36 | 2024-2025 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $66.34 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.03 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $52.02 | 2021-2023 | Ajovy |
| Idorsia Pharmaceuticals US INC | $51.24 | 2022-2023 | Quviviq |
| Amarin Pharma, INC. | $45.22 | 2021 | |
| Sanofi-Aventis U.S. LLC | $41.65 | 2020-2025 | |
| Edwards Lifesciences Corporation | $36.02 | 2025 | Sapien 3 Ultra Resilia |
| Eisai INC. | $35.00 | 2024-2025 | |
| Medtronic, INC. | $34.05 | 2024 | Interstim |
| Nevro Corp. | $29.27 | 2024 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $28.49 | 2020-2022 | |
| Beta Bionics, INC. | $23.86 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Inspire Medical Systems, INC. | $22.85 | 2025 | Inspire |
| Sanofi Pasteur INC. | $21.82 | 2025 | |
| Vital Connect, INC | $21.65 | 2025 | Vitalpatch Rtm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.44 | 2022 | |
| Biogen, INC. | $20.78 | 2025 | Leqembi |
| Bausch Health US, LLC | $19.39 | 2021 | |
| Philips North America LLC | $19.35 | 2024 | (Ck7) Extended Holter |
| Bardy Diagnostics, INC. | $18.72 | 2021 | |
| Phadia US INC. | $18.46 | 2025 | Immunocap |
| Linus Health, INC. | $14.66 | 2024 | Core Cognitive Evaluation |
| Optos, INC. | $13.91 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Currax Pharmaceuticals LLC | $13.86 | 2021 | |
| Genentech USA, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.